Molecular Predictors of Efficacy of Adjuvant Weekly Paclitaxel in Early Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-009-0663-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Caveolin-1 Expression Predicts Efficacy of Weekly Nab-Paclitaxel Plus Gemcitabine for Metastatic Breast Cancer in the Phase II Clinical Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Medical Treatment of Early Breast Cancer. I: Adjuvant Treatment

BMJ
2006English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Current Treatment of Early Breast Cancer: Adjuvant and Neoadjuvant Therapy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Cancers
Cancer ResearchOncology
2019English

Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2011English

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer

Current Treatment Options in Oncology
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy